Clinical Trials for Refractory B Lymphoblastic Lymphoma

Find clinical trials for refractory b lymphoblastic lymphoma. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia

NCT ID: NCT02981628

This clinical trial is investigating a treatment called inotuzumab ozogamicin for younger patients, aged 1 to 21, who have certain types of blood cancers, including B-lymphoblastic lymphoma and B a...

Recruiting

Phase: PHASE2 Type: interventional Locations: New Haven, Connecticut, United States, Brooklyn, New York, United States +166 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions